TABLE 2.

Subjects available for evaluation of microbiologic endpoints

^aThe denominator for the calculation of the percentage is the number of subjects with an annual sample.

^bEvaluable subjects had aztreonam MIC data available from 2 visits, as indicated by the left- and righthand ends of the gray bars. For example, 262 subjects were evaluable at year 3 for the primary endpoint analysis because they had data available for year 2 and year 3. Note that subjects could move between AZLI use categories (yes/no for each year) across the study.

^cEvaluable subjects had baseline data available and aztreonam MIC data from the relevant year. For example, 267 subjects were evaluable to assess the change from the baseline MIC to the year 3 MIC.